Archives

2022

July 10, 2023 11:22 am Published by

CE certificate issued for Broncholab® platform for use in the EU ISO 13485:2016 certification issued for Fluidda’s Quality Management System

2021

July 10, 2023 11:21 am Published by

Over 65 scientific publications in peer-reviewed magazines on respiratory research with FRI.

2020

April 20, 2021 11:07 pm Published by

Fluidda’s Broncholab® platform cleared by the FDA

2019

October 20, 2019 9:13 am Published by

Collaboration with Kreivohealth in Asia/Pacific. Opening Fluidda office in Singapore.

2018

October 20, 2019 9:12 am Published by

FDA letter of support encouraging further development of FRI for the use in bioequivalence studies.

2017

October 20, 2019 9:12 am Published by

Opening Fluidda office in Los Angeles.

2015

October 20, 2019 9:11 am Published by

First use of FRI in a clinical trial related to CF; Opening Fluidda office in Portugal; European Business Award.

2014

October 20, 2019 9:11 am Published by

First use of FRI in a clinical trial related to IPF.

2012

October 20, 2019 9:11 am Published by

Opening Fluidda office in New York. 

2009

October 20, 2019 9:07 am Published by

First use of FRI in a clinical trial related to COPD.